📣 VC round data is live. Check it out!

Agilon Health Valuation Multiples

Discover Agilon Health's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Burjeel Holdings, Dr Agarwals, Ramsay Santé, Almoosa Health and more.

Agilon Health Overview

About Agilon Health

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.


Founded

2017

HQ

United States

Employees

1.1K

Financials (LTM)

Revenue: $6B
EBITDA: ($163M)

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Agilon Health Financials

Agilon Health reported last 12-month revenue of $6B and negative EBITDA of ($163M).

In the same LTM period, Agilon Health generated $54M in gross profit, ($163M) in EBITDA losses, and had net loss of ($245M).

Revenue (LTM)


Agilon Health P&L

In the most recent fiscal year, Agilon Health reported revenue of $6B and EBITDA of ($296M).

Agilon Health is unprofitable as of last fiscal year, with gross margin of (3%), EBITDA margin of (5%), and net margin of (7%).

See analyst estimates for Agilon Health
LTMLast FY202320242025202620272028
Revenue$6B$6B$4B$6B$6B
Gross Profit$54M($160M)$70M$5M($160M)
Gross Margin1%(3%)2%0%(3%)
EBITDA($163M)($296M)($168M)($218M)($369M)
EBITDA Margin(3%)(5%)(4%)(4%)(6%)
EBIT Margin(4%)(6%)(5%)(5%)(7%)
Net Profit($245M)($391M)($263M)($260M)($391M)
Net Margin(4%)(7%)(6%)(4%)(7%)

Financial data powered by Morningstar, Inc.

Agilon Health Stock Performance

Agilon Health has current market cap of $2B, and enterprise value of $1B.

Market Cap Evolution


Agilon Health's stock price is $92.54.

Agilon Health share price increased by 0.3% in the last 30 days, and by 3926.7% in the last year.

Agilon Health has an EPS (earnings per share) of $-23.46.

See more trading valuation data for Agilon Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$2B0.3%0.3%1069.9%3926.7%$-23.46

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Agilon Health Valuation Multiples

Agilon Health trades at 0.2x EV/Revenue multiple, and (8.3x) EV/EBITDA.

See NTM and 2027E valuation multiples for Agilon Health

EV / Revenue (LTM)


Agilon Health Financial Valuation Multiples

As of June 2, 2026, Agilon Health has market cap of $2B and EV of $1B.

Agilon Health has a P/E ratio of (6.3x).

LTMLast FY202320242025202620272028
EV/Revenue0.2x0.2x0.3x0.2x0.2x
EV/EBITDA(8.3x)(4.5x)(8.0x)(6.2x)(3.6x)
EV/EBIT(5.9x)(3.6x)(5.8x)(4.7x)(3.2x)
EV/Gross Profit24.8x(8.4x)19.3xn/m(8.4x)
P/E(6.3x)(3.9x)(5.9x)(5.9x)(3.9x)
EV/FCF(13.8x)(10.6x)(7.2x)(13.6x)(9.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Agilon Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Agilon Health Margins & Growth Rates

Agilon Health decreased revenue by 4% and EBITDA by 107% in the last fiscal year.

In the most recent fiscal year, Agilon Health reported gross margin of (3%), EBITDA margin of (5%), and net margin of (7%).

See estimated margins and future growth rates for Agilon Health

Agilon Health Margins

Last FY202420252026202720282029
Gross Margin(3%)0%(3%)5%
EBITDA Margin(5%)(4%)(6%)0%
EBIT Margin(6%)(5%)(7%)(0%)
Net Margin(7%)(4%)(7%)(1%)
FCF Margin(2%)(2%)(3%)(1%)

Agilon Health Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(4%)40%(2%)(4%)
Gross Profit Growth(270%)(93%)(3406%)(270%)
EBITDA Growth(107%)30%69%(106%)
EBIT Growth(93%)24%48%(94%)
Net Profit Growth(89%)(1%)50%(89%)
FCF Growth(55%)(47%)50%(61%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Agilon Health Operational KPIs

Agilon Health's revenue per employee in the last FY averaged $5.5M, while opex per employee averaged $0.2M for the same period.

Agilon Health's Rule of 40 is (3%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Agilon Health's Rule of X is (9%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Agilon Health
LTMLast FY202320242025202620272028
Rule of 40(2%)(3%)---
Bessemer Rule of X(2%)(9%)---
Revenue per Employee-$5.5M---
Opex per Employee-$0.2M---
G&A Expenses to Revenue4%4%7%4%4%
Opex to Revenue-5%7%5%5%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Agilon Health Competitors

Agilon Health competitors include Burjeel Holdings, Dr Agarwals, Ramsay Santé, Almoosa Health, OdontoPrev, Aevis Victoria, Siloam Hospitals, Surgery Partners, Med Life and Ardent Health.

Most Agilon Health public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Burjeel Holdings1.5x1.5x7.7x7.8x
Dr Agarwals7.7x7.5x26.0x27.5x
Ramsay Santé1.0x-8.5x-
Almoosa Health4.4x4.2x17.4x-
OdontoPrev-3.3x-10.4x
Aevis Victoria1.7x1.9x23.8x20.4x
Siloam Hospitals2.4x2.4x9.9x9.6x
Surgery Partners1.7x1.7x9.9x10.5x

This data is available for Pro users. Sign up to see all Agilon Health competitors and their valuation data.

Start Free Trial

Agilon Health VC Funding History

Before going public, Agilon Health raised $2B in total equity funding, across 1 round.


Agilon Health Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
May-23Secondary - public-$2B-On May 15, 2023, agilon health announced a secondary public offering in which selling shareholder CD&R Vector Holdings, an affiliate of Clayton, Dubilier & Rice, offered 70 million shares of common stock. The company concurrently announced a share repurchase program to buy approximately $200 million of its own stock from underwriters at the same per-share price, funded from cash on hand. This was a secondary offering (existing shareholder sale) rather than a primary capital raise by the company itself. In Q1 2023, agilon health reported total revenue of $1.14 billion, representing 74% year-over-year growth compared to $653 million in Q1 2022. The company's Medicare Advantage membership stood at 402,200 members as of Q1 2023, with total platform members reaching 490,900 including ACO REACH beneficiaries. agilon health operates as a value-based care platform partnering with physician groups, having established presence in 30+ diverse communities with a network of 2,700+ primary care physicians. The company had previously raised $1.058 billion through its IPO on April 15, 2021.

Acquisitions by Agilon Health

Agilon Health has acquired 1 company to date.

Last acquisition by Agilon Health was on March 1st 2023. Agilon Health acquired MphRx for $45M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Agilon Health

MphRx
Description
MphRx is a cloud platform developed by Mumbai-based Prognosys Medical Systems that aggregates patient data from EMRs, labs, radiology, cardiology, and billing systems for health providers in the United States and India. HIPAA-compliant web and mobile apps deliver unified views and BizEye analytics dashboards for operational insights. Deployed by major hospital networks, it supports care coordination and real-time financial reporting.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date1 Mar 2023
Valuation$45M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Agilon Health acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Agilon Health

When was Agilon Health founded?Agilon Health was founded in 2017.
Where is Agilon Health headquartered?Agilon Health is headquartered in United States.
How many employees does Agilon Health have?As of today, Agilon Health has over 1K employees.
Who is the CEO of Agilon Health?Agilon Health's CEO is Jeffrey A. Schwaneke.
Is Agilon Health publicly listed?Yes, Agilon Health is a public company listed on NYSE.
What is the stock symbol of Agilon Health?Agilon Health trades under AGL ticker.
When did Agilon Health go public?Agilon Health went public in 2021.
Who are competitors of Agilon Health?Agilon Health main competitors include Burjeel Holdings, Dr Agarwals, Ramsay Santé, Almoosa Health, OdontoPrev, Aevis Victoria, Siloam Hospitals, Surgery Partners, Med Life, Ardent Health.
What is the current market cap of Agilon Health?Agilon Health's current market cap is $2B.
What is the current revenue of Agilon Health?Agilon Health's last 12 months revenue is $6B.
What is the current revenue growth of Agilon Health?Agilon Health revenue growth (NTM/LTM) is 0%.
What is the current EV/Revenue multiple of Agilon Health?Current revenue multiple of Agilon Health is 0.2x.
Is Agilon Health profitable?No, Agilon Health is not profitable.
What is the current EBITDA of Agilon Health?Agilon Health has negative EBITDA and is not profitable.
What is Agilon Health's EBITDA margin?Agilon Health's last 12 months EBITDA margin is (3%).
What is the current EV/EBITDA multiple of Agilon Health?Current EBITDA multiple of Agilon Health is (8.3x).
What is the current FCF of Agilon Health?Agilon Health's last 12 months FCF is ($98M).
What is Agilon Health's FCF margin?Agilon Health's last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of Agilon Health?Current FCF multiple of Agilon Health is (13.8x).
How many companies Agilon Health has acquired to date?As of June 2026, Agilon Health has acquired 1 company.
What was the largest acquisition by Agilon Health?$45M acquisition of MphRx on 1st March 2023 was the largest M&A Agilon Health has done to date.
What companies Agilon Health acquired?Agilon Health acquired MphRx.
In how many companies Agilon Health has invested to date?Agilon Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Agilon Health

Lists including Agilon Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial